Reporter brief
Evaluation of the Impact of Physical Exercise on Metabolic Dysfunction-associated Steatotic Liver Disease in the Elderly
What happened
Trial registry update: RECRUITING. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- This document reports only the trial protocol, not actual findings or efficacy of exercise for liver disease
- No participant enrollment numbers, completion rates, or baseline characteristics are provided
- The study design creates an imbalance: only one group (middle-aged, low-risk MASLD) has a control arm without exercise, limiting causal inference for other comparisons
Study design and sample
Rct; Human.
Adults with metabolic dysfunction-associated steatotic liver disease (MASLD) or at-risk metabolic dysfunction-associated steatohepatitis (MASH): middle-aged adults (40-60 years old) and older adults (70 years and older) of any sex
- Design
- Rct
- Sample
- —
- Journal
- Consorcio Centro de Investigación Biomédica en Red (CIBER)
- Published
- Oct 26, 2026
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Exercise timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.